NOV 08, 2020 8:30 AM PST

Can Cannabis Treat Epilepsy?

WRITTEN BY: Annie Lennon

There has been growing interest in recent years for cannabis to treat central nervous system disorders. And so far, there is reasonable evidence to suggest that cannabidiol (CBD), a nonpsychoactive compound found in cannabis, is largely effective in reducing symptoms of epilepsy. 

One such piece of evidence comes from a randomized clinical trial conducted in 2017 on Epidolex, an oral CBD solution, on children aged between 2 and 18 with Dravet Syndrome, a childhood-onset version of epilepsy that is especially difficult to control with available therapies. Including 120 participants, each received either 20mg of CBD per kilogram of body weight in addition to their standard drug regimes or a placebo. All in all, participants using CBD saw their monthly seizures reduce 39%, as opposed to 13% in the placebo group. 

A further study conducted in 2018 included 225 patients aged between 2 and 55 across 30 centers with Lennox-Gastaut syndrome, a severe form of childhood-onset epilepsy. From this study, researchers found that patients who received 20mg of CBD per kilogram of body weight had 42% fewer seizures. Meanwhile, those on 10mg per kilogram of body weight saw a reduction of 37% in seizure frequency, whereas those on placebos saw a reduction of 17%. 

These results were once again echoed in a study conducted in 2018 between the Netherlands, US, and Poland on 171 patients also aged between 2 and 5 with Lennox-Gastaut Syndrome. In this case, researchers found that patients receiving 20mg of CBD per kilogram of body weight alongside their existing drug regimes saw an average reduction of monthly seizures of 44% compared to 22% for those receiving a placebo. 

Also of note is that patients taking CBD across these studies noted improvements in their mood, sleep quality, and cognitive abilities. They also regularly noted having an increased appetite. As such, it comes as little surprise that Epidolex was approved by the FDA in 2018 to treat those aged two and above for epilepsy caused by Lennox-Gastaut or Dravet syndrome. 

That said, while CBD may hail benefits for many, other research has shown that its effects are not universal. While some surveys suggest that the cannabinoid can reduce seizures by up to 50%, others report no reduction. Some have even reported an increase in seizures following CBD usage. 

As such, while CBD seems to have positive effects on many with epilepsy, it should not be considered a silver bullet- especially as even in those in which it has an effect, seizures are still experienced. To better understand why this is the case and how to perhaps improve the effects of CBD on the condition, further research is needed to understand the mechanisms of CBD in the brain, epilepsy, and how the two interact. 

 

Sources: Pub MedCannigma

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JUL 13, 2020
Cannabis Sciences
Over Half of CBD Products Falsely Labeled
JUL 13, 2020
Over Half of CBD Products Falsely Labeled
Tests conducted by the US Food and Drug Agency (FDA) have found that 55% of cannabidiol (CBD) products contain significa ...
JUL 23, 2020
Cannabis Sciences
Lab Tests Show Levels of THC Can Rise in CBD Oil During Storage
JUL 23, 2020
Lab Tests Show Levels of THC Can Rise in CBD Oil During Storage
To be federally legal in all states CBD (cannabidiol) oil must contain less than 0.3 percent of the psychoactive ingredi ...
AUG 28, 2020
Cannabis Sciences
CBD-Infused Drinks Not up To Scratch
AUG 28, 2020
CBD-Infused Drinks Not up To Scratch
A new analysis suggests that if you buy up a CBD-laced beverage you might not get what you were expecting. Not that any ...
SEP 03, 2020
Cannabis Sciences
Cannabis Could Help Reduce Diabetes Risk in Hepatitis C Patients
SEP 03, 2020
Cannabis Could Help Reduce Diabetes Risk in Hepatitis C Patients
It’s known that patients with hepatitis C have an increased risk of developing insulin resistance and diabetes. &n ...
SEP 24, 2020
Health & Medicine
Pregnancy Cannabis Use Linked With Psychotic Behaviors in Offspring
SEP 24, 2020
Pregnancy Cannabis Use Linked With Psychotic Behaviors in Offspring
Women are already warned that using marijuana during pregnancy might affect their baby’s growth in the womb, but a ...
NOV 10, 2020
Health & Medicine
Users of Medical Cannabis Reduce Their Alcohol Intake
NOV 10, 2020
Users of Medical Cannabis Reduce Their Alcohol Intake
Results from the Canadian Cannabis Patient Survey 2019 (CCPS 2019), a large cross-sectional survey of medical cannabis p ...
Loading Comments...